Determination of the efflux pump mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor
Tohidpour A, Peerayeh SN, Mehrabadi JF, Rezaei YH. Determination of the efflux pump mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor. Curr Microbiol 2009;59:352-355.
Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals
Rogues AM, Dumartin C, Amadéo B, et al. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect Control Hosp Epidemiol 2007;28:1389-1395.
Assessment of effects of fluoroquinolone formulary changes on gram-negative susceptibility and MRSA isolation rates using interrupted time series analysis
Bosso JA, Mauldin PD. Assessment of effects of fluoroquinolone formulary changes on gram-negative susceptibility and MRSA isolation rates using interrupted time series analysis. Antimicrob Agents Chemother 2006;50:2106-2112.
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 Tracking Resistance in the United States Today surveillance studies
Karlowsky JA, Jones ME, Thornsberry C, Evangelista AT, Cheung Yee Y, Sahm DF. Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 Tracking Resistance in the United States Today surveillance studies. Clin Infect Dis 2005;40:S89-S98.
World Health Organization (WHO). WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2011. http://www.whocc.no/atcddd/. Accessed July 17, 2009.